Wencong Liu

Wencong Liu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JZJinping Zhang
Jinping Zhang
KCKecheng Chen
Kecheng Chen
CDChuanbo Ding
Chuanbo Ding
SSShuwen Sun
Shuwen Sun
XSXinxin She
Xinxin She
WLWencong Liu
Wencong Liu

24 July 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
ZZzhangshuai zhang
zhangshuai zhang
HLHongyuan Liu
Hongyuan Liu
WLWei Li
Wei Li
XLXinglong Liu
Xinglong Liu
LMLina Ma
Lina Ma
WLWencong Liu
Wencong Liu

29 October 2021 in Food & Function
Verified
Journal Article
Closed access
PDF file
XLXing-Long Liu
Xing-Long Liu
YZYing-Chun Zhao
Ying-Chun Zhao
HZHong-Yan Zhu
Hong-Yan Zhu
MWMing Wu
Ming Wu
YZYi-Nan Zheng
Yi-Nan Zheng
WLWencong Liu
Wencong Liu
Aging and aging-related metabolic complications are global problems that seriously threaten public health. Taxifolin (TAX) is a novel health food and has been widely proved to have a variety of biological activities used in food and medicine. However, the delayed effect of TAX on the aging process has not been investigated. The purpose of this study is to explore the role of TAX as a natural active substance on aging brain tissue induced by D-galactose (D-Gal) and to determine the effect of supplementing TAX on the metabolism of the intestinal flora in aging bodies. The aging model was established by intraperitoneal injection of D-Gal (800 mg kg−1) once per 3 days for 12 weeks, and TAX (20 and 40 mg kg−1) was administered daily by oral gavage after 6 weeks of induction with D-Gal. After testing aging mice in an eight-arm maze, the results showed that TAX treatment significantly restored spatial learning and memory impairment. Moreover, long-term D-Gal treatment incited cholinergic dysfunction of aging mice, and H&E staining revealed obvious histopathological damage and structural disorder in the hippocampus of mouse brain tissue, while TAX treatment significantly reversed these changes. Importantly, supplementing with TAX significantly mitigated oxidative stress injury by alleviating the levels of reactive oxygen species (ROS) and malondialdehyde (MDA) while increasing antioxidant enzymes. Furthermore, TAX decreased the apoptosis of the aging brain by regulating the phosphorylation levels of phosphatidylinositol 3-kinase (PI3K), protein kinase B (AKT), and activating nuclear factor-erythroid 2-related factor 2 (Nrf2), nuclear heme oxygenase-1 (HO-1), and NADH dehydrogenase quinone 1 (NQO1) to maximally moderate the oxidative stress injury that occurred after D-Gal induction. In addition, 16S rDNA analysis revealed that TAX treatment decelerated the D-gal-induced aging process by regulating the composition of the intestinal flora and abundance of beneficial bacteria, including Enterorhabdus, Clostridium, Bifidobacterium, and Parvibacter. In conclusion, the results of this study demonstrated that TAX alleviated oxidative stress injury in mice aged by D-Gal and also confirmed that TAX improved the aging process by regulating intestinal microbes, which provides the possibility of prevention and treatment for aging and metabolic disorders through the potential food health factors.

18 October 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YZYingchun Zhao
Yingchun Zhao
XLXinglong Liu
Xinglong Liu
YZYinan Zheng
Yinan Zheng
WLWencong Liu
Wencong Liu
CDChuanbo Ding
Chuanbo Ding
Aronia melanocarpais a natural medicinal plant that has a variety of biological activities, its fruit is often used for food and medicine.Aronia melanocarpapolysaccharide (AMP) is the main component of theAronia melanocarpafruit. This research evaluated the delay and protection of AMP obtained fromAronia melanocarpafruit on aging mice byd-Galactose (D-Gal) induction and explored the effect of supplementing AMP on the metabolism of the intestinal flora of aging mice. The aging model was established by intraperitoneal injection of D-Gal (200 mg/kg to 1000 mg/kg) once per 3 days for 12 weeks. AMP (100 and 200 mg/kg) was given daily by oral gavage after 6 weeks of D-Gal-induced. The results showed that AMP treatment significantly improved the spatial learning and memory impairment of aging mice determined by the eight-arm maze test. H&E staining showed that AMP significantly reversed brain tissue pathological damage and structural disorders. AMP alleviated inflammation and oxidative stress injury in aging brain tissue by regulating the AMPK/SIRT1/NF-κB and Nrf2/HO-1 signaling pathways. Particularly, AMP reduced brain cell apoptosis and neurological deficits by activating the PI3K/AKT/mTOR signaling pathway and its downstream apoptotic protein family. Importantly, 16S rDNA analysis indicated the AMP treatment significantly retarded the aging process by improving the composition of intestinal flora and abundance of beneficial bacteria. In summary, this study found that AMP delayed brain aging in mice by inhibiting inflammation and regulating intestinal microbes, which providing the possibility for the amelioration and treatment of aging and related metabolic diseases.

8 July 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YZYingchun Zhao
Yingchun Zhao
XLXinglong Liu
Xinglong Liu
XPXiaojuan Peng
Xiaojuan Peng
YZYinan Zheng
Yinan Zheng
ZCZhiqiang Cheng
Zhiqiang Cheng
CDChuanbo Ding
Chuanbo Ding

15 November 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
YZYingchun Zhao
Yingchun Zhao
XLXinglong Liu
Xinglong Liu
CDChuanbo Ding
Chuanbo Ding
YGYan Gu
Yan Gu
WLWencong Liu
Wencong Liu
As a natural active substance, dihydromyricetin (DHM) has been proven to have good hepatoprotective activity. However, the therapeutic effect of DHM on liver fibrosis, which has become a liver disease threatening the health of people around the world, has not been studied to date. The purpose of this study was to investigate the effect of DHM as a new nutritional supplement on thioacetamide (TAA)-induced liver fibrosis. The liver fibrosis model was established by intraperitoneal injection of TAA (200 mg/kg, every 3 days) for 8 weeks, and oral administration of DHM (20 mg/kg and 40 mg/kg, daily) after 4 weeks of TAA-induced liver fibrosis. The results showed that DHM treatment significantly inhibited the activities of alanine aminotransferase (ALT) (37.81 ± 7.62 U/L) and aspartate aminotransferase (AST) (55.18 ± 10.94 U/L) in serum of liver fibrosis mice, and increased the levels of superoxide dismutase (SOD) and glutathione (GSH) while reversed the level of malondialdehyde (MDA). In addition, histopathological examination illustrated that TAA induced the inflammatory infiltration, apoptosis and fibroatherosclerotic deposition in liver, which was further confirmed by western-blot and immunofluorescence staining. Moreover, DHM inhibited hepatocyte apoptosis by regulating the phosphorylation level of phosphatidylinositol 3-kinase (PI3K), protein kinase-B (AKT) and its downstream apoptotic protein family. Interestingly, immunofluorescence staining showed that DHM treatment significantly inhibited alpha smooth muscle actin (α-SMA), which was a marker of hepatic stellate cell activation, and regulated the expression of transforming growth factor (TGF-β1). Importantly, supplementation with DHM significantly inhibited the release of nuclear factor kappa-B (NF-κB) signaling pathway and pro-inflammatory factors in liver tissue induced by TAA, and improved liver fiber diseases, such as tumor necrosis factor alpha (TNF-α) and recombinant rat IL-1β (IL-1β). In conclusion, the evidence of this study revealed that DHM is a potential hepatoprotective and health factor, and which also provides the possibility for the treatment of liver fibrosis.